首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Advances in hematology

缩写:

ISSN:1687-9104

e-ISSN:1687-9112

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引164
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Evgeny Klyuchnikov,Ulrike Bacher,Nicolaus Kröger et al. Evgeny Klyuchnikov et al.
Despite the favorable prognosis of most patients with Hodgkin's Lymphoma (HL), 15-20% of patients remain refractory to chemoradiotherapy, and 20-40% experience relapses following autologous stem cell transplantation (SCT) being used as salv...
Kheng-Wei Yeoh,N George Mikhaeel Kheng-Wei Yeoh
Hodgkin's Lymphoma was incurable until the advent of effective therapeutic radiation around the first half of the 20th century. As survival rates improved, the long-term toxicities from radiotherapy began to emerge. This together with the a...
Liesbeth Bieghs,Jo Caers,Elke De Bruyne et al. Liesbeth Bieghs et al.
Multiple myeloma (MM) is the second most commonly diagnosed hematological malignancy, characterized by a monoclonal proliferation of malignant cells in the bone marrow. Despite recent advances in treatment strategies, MM remains incurable a...
S Montes-Moreno S Montes-Moreno
Thomas Hodgkin's and Samuel Wilks first recognized Hodgkin disease in the first half of the 19th century. Initially described as lymphogranulomatosis, it was later recognized to be a lymphoid neoplasm derived from B cells and was classified...
Sean Grimm,Marc Chamberlain Sean Grimm
Hodgkin's lymphoma is a hematolymphoid neoplasm, primarily of B cell lineage, that has unique histologic, immunophenotypic, and clinical features. Neurologic complications of Hodgkin's Lymphoma can be separated into those that result direct...
Claudio Fozza,Maurizio Longinotti Claudio Fozza
In hematologic malignancies, the microenvironment is often characterized by nonneoplastic cells with peculiar phenotypic and functional features. This is particularly true in Hodgkin's lymphoma (HL), in which T lymphocytes surrounding Hodgk...
Antonio Amato,Maria Pia Cappabianca,Alessia Colosimo et al. Antonio Amato et al.
The aim of this study was to describe the changing pattern of mutational spectrum of β-thalassemia (β-thal) in the Lazio region (Central Italy), as consequence of recent demographic variations. From 1994 until present, 256 immigrant subje...
Michele Spina,Antonino Carbone,Annunziata Gloghini et al. Michele Spina et al.
Hodgkin lymphoma (HL) represents one of the most common non-AIDS-defining cancers with an increasing incidence overtime. Clinically, patients present advanced stages of disease with extranodal involvement in the majority of cases. In the la...
Sabrina Uhrmacher,Felix Erdfelder,Karl-Anton Kreuzer Sabrina Uhrmacher
New therapeutic strategies developed recently for chronic lymphocytic leukemia (CLL) have led to remarkable treatment response rates and complete hematological remissions. This means highly sensitive and specific techniques are increasingly...
Vinod Pullarkat Vinod Pullarkat
Recipients of hematopoietic stem cell transplantation (HSCT) frequently have iron overload resulting from chronic transfusion therapy for anemia. In some cases, for example, in patients with myelodysplastic syndromes and thalassemia, this c...